What are Bio-Rad Laboratories, Inc.'s profit margins?

Bio-Rad Laboratories, Inc. (BIO.B) runs a 51.9% gross margin and a 8.8% operating margin, with a 6.5% net margin.

Where do Bio-Rad Laboratories, Inc.'s ratios come from?

Every ratio is computed from Bio-Rad Laboratories, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Bio-Rad Laboratories, Inc. BIO.B Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	51.9%-1.9pp	53.7%+0.3pp	53.4%-2.5pp	55.9%-0.2pp
Net margin	29.4%+101pp	-71.9%-48.0pp	-23.9%+106pp	-129.4%-275pp
Returns
Return on equity	10.8%+34.9pp	-24.1%-17.1pp	-6.9%+24.2pp	-31.1%-67.2pp
Return on invested capital	10.7%+7.6pp	3.1%-0.2pp	3.3%-0.7pp	4%-0.4pp
Efficiency
Asset turnover	0.3×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×
Liquidity
Current ratio	5.6×-0.9×	6.5×+0.6×	5.8×+0.3×	5.6×+2.6×
Leverage
Debt-to-equity	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.1×+0.1×
Per Share
Book value per share	$273.22+17.3%	$232.84-22.2%	$299.26-7.3%	$322.82-28.7%
Valuation
Market capitalization	$8.17B-11.1%	$9.2B-2.3%	$9.41B-25.0%	$12.54B-44.5%
Price / earnings	10.8×—	——	——	——
Price / sales	3.2×-0.4×	3.6×+0.1×	3.5×-1.0×	4.5×-3.3×
Price / book	1.1×-0.3×	1.4×+0.3×	1.1×-0.2×	1.3×-0.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bio-Rad Laboratories, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Bio-Rad Laboratories, Inc.'s profit margins?: Bio-Rad Laboratories, Inc. (BIO.B) runs a 51.9% gross margin and a 8.8% operating margin, with a 6.5% net margin.
Where do Bio-Rad Laboratories, Inc.'s ratios come from?: Every ratio is computed from Bio-Rad Laboratories, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.